These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9484762)

  • 21. CMV DNA in blood and CSF of HIV infected patients.
    Stanojevic M; Zerjav S; Jevtovic D; Salemovic D; Ranin J
    Virus Res; 2002 Apr; 85(1):117-22. PubMed ID: 11955644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfusion-transmitted cytomegalovirus (CMV) infections in a murine model: characterization of CMV-infected donor mice.
    Roback JD; Su L; Newman JL; Saakadze N; Lezhava LJ; Hillyer CD
    Transfusion; 2006 Jun; 46(6):889-95. PubMed ID: 16734804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of cytomegalovirus-infected cells by flow cytometry and fluorescence in suspension hybridisation (FLASH) using DNA probes labeled with biotin by polymerase chain reaction.
    Link H; Battmer K; Kleine HD
    J Med Virol; 1992 Jun; 37(2):143-8. PubMed ID: 1321224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience.
    Favi E; Santangelo R; Iesari S; Morandi M; Marcovecchio GE; Trecarichi EM; Salerno MP; Ferraresso M; Citterio F; Romagnoli J
    Transplant Proc; 2017 Oct; 49(8):1766-1772. PubMed ID: 28923622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of reactivity to CMV pp65 antigenemia testing in a patient with CMV disease following allogeneic bone marrow transplant.
    Seropian S; Ferguson D; Salloum E; Cooper D; Landry ML
    Bone Marrow Transplant; 1998 Sep; 22(5):507-9. PubMed ID: 9733277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and monitoring of human cytomegalovirus infection in bone marrow transplant recipients by quantitative competitive PCR.
    Ziyaeyan M; Sabahi F; Alborzi A; Mahboudi F; Kazemnejad A; Ramzi M; Moravej A; Jaberi MM
    Exp Clin Transplant; 2006 Jun; 4(1):470-4. PubMed ID: 16827646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Blood leukocytes are not a primary latent site of cytomegalovirus].
    Hackstein H; Böttcher K; Merz H; Kirchner H; Bein G
    Beitr Infusionsther Transfusionsmed; 1996; 33():235-40. PubMed ID: 8974700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural cytotoxic activity against cytomegalovirus-infected target cells following marrow transplantation.
    Bowden RA; Day LM; Amos DE; Meyers JD
    Transplantation; 1987 Oct; 44(4):504-8. PubMed ID: 2823422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of the cytomegalovirus by the polymerase chain reaction DNA amplification in a kidney transplanted patient.
    Ergazaki M; Liloglou T; Koffa M; Kostakis A; Haliassos A; Spandidos DA
    In Vivo; 1993; 7(6A):531-4. PubMed ID: 8193272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.
    Schvoerer E; Henriot S; Zachary P; Freitag R; Fuchs A; Fritsch S; Risch S; Meyer N; Caillard S; Lioure B; Stoll-Keller F
    J Med Virol; 2005 May; 76(1):76-81. PubMed ID: 15778970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?
    Kekre N; Tokessy M; Mallick R; McDiarmid S; Huebsch L; Bredeson C; Allan D; Tay J; Tinmouth A; Sheppard D
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1719-24. PubMed ID: 24099958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors.
    Söderberg-Nauclér C; Fish KN; Nelson JA
    Cell; 1997 Oct; 91(1):119-26. PubMed ID: 9335340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral activity against CMV-infected fibroblasts in pediatric patients transplanted with CD34(+)-selected allografts from alternative donors.
    Lang P; Griesinger A; Hamprecht K; Feuchtinger T; Schumm M; Neuhäuser F; Greil J; Martin D; Handgretinger R; Niethammer D
    Hum Immunol; 2004 May; 65(5):423-31. PubMed ID: 15172441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytomegalovirus infection in leucocytes after bone marrow transplantation demonstrated by mRNA in situ hybridization.
    Link H; Battmer K; Stumme C
    Br J Haematol; 1993 Nov; 85(3):573-7. PubMed ID: 8136281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome.
    Enders G; Bäder U; Lindemann L; Schalasta G; Daiminger A
    Prenat Diagn; 2001 May; 21(5):362-77. PubMed ID: 11360277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes.
    Gehrz RC; Rutzick SR
    Clin Exp Immunol; 1985 Jul; 61(1):80-9. PubMed ID: 2994924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of cytomegalovirus infection on breastfeeding transmission of HIV and on the health of infants born to HIV-infected mothers.
    Chang TS; Wiener J; Dollard SC; Amin MM; Ellington S; Chasela C; Kayira D; Tegha G; Kamwendo D; Jamieson DJ; van der Horst C; Kourtis AP;
    AIDS; 2015 Apr; 29(7):831-6. PubMed ID: 25985405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid detection of cytomegalovirus antigen on alveolar cells in bronchoalveolar fluid from transplant patients with cytomegalovirus pneumonia.
    Heurlin N; Markling L; Barkholt L; Lönnqvist B; Andersson J; Ringdén O
    Clin Transplant; 1994 Oct; 8(5):466-73. PubMed ID: 7819613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strain specific effects of cytomegalovirus on endothelial cells: implications for investigating the relationship between CMV and cardiac allograft vasculopathy.
    Srivastava R; Curtis M; Hendrickson S; Burns WH; Hosenpud JD
    Transplantation; 1999 Nov; 68(10):1568-73. PubMed ID: 10589956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The natural course of primary cytomegalovirus infection in blood donors.
    Ziemann M; Unmack A; Steppat D; Juhl D; Görg S; Hennig H
    Vox Sang; 2010 Jul; 99(1):24-33. PubMed ID: 20074081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.